These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28401002)

  • 1. Gpr110 deficiency decelerates carcinogen-induced hepatocarcinogenesis via activation of the IL-6/STAT3 pathway.
    Ma B; Zhu J; Tan J; Mao Y; Tang L; Shen C; Zhang H; Kuang Y; Fei J; Yang X; Wang Z
    Am J Cancer Res; 2017; 7(3):433-447. PubMed ID: 28401002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gankyrin drives malignant transformation of chronic liver damage-mediated fibrosis via the Rac1/JNK pathway.
    Zhao X; Fu J; Xu A; Yu L; Zhu J; Dai R; Su B; Luo T; Li N; Qin W; Wang B; Jiang J; Li S; Chen Y; Wang H
    Cell Death Dis; 2015 May; 6(5):e1751. PubMed ID: 25950481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatoprotective versus oncogenic functions of STAT3 in liver tumorigenesis.
    Wang H; Lafdil F; Wang L; Park O; Yin S; Niu J; Miller AM; Sun Z; Gao B
    Am J Pathol; 2011 Aug; 179(2):714-24. PubMed ID: 21684247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrosis-associated hepatocarcinogenesis revisited: Establishing standard medium-term chemically-induced male and female models.
    Romualdo GR; Prata GB; da Silva TC; Fernandes AAH; Moreno FS; Cogliati B; Barbisan LF
    PLoS One; 2018; 13(9):e0203879. PubMed ID: 30212575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of GPR110 in lung cancer progression.
    Ma B; Zhu J; Su J; Pan F; Ji Y; Luan L; Huang J; Hou Y
    Ann Transl Med; 2020 Jun; 8(12):745. PubMed ID: 32647670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT3-mediated attenuation of CCl4-induced mouse liver fibrosis by the protein kinase inhibitor sorafenib.
    Deng YR; Ma HD; Tsuneyama K; Yang W; Wang YH; Lu FT; Liu CH; Liu P; He XS; Diehl AM; Gershwin ME; Lian ZX
    J Autoimmun; 2013 Oct; 46():25-34. PubMed ID: 23948302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hesperidin protects against chemically induced hepatocarcinogenesis via modulation of Nrf2/ARE/HO-1, PPARγ and TGF-β1/Smad3 signaling, and amelioration of oxidative stress and inflammation.
    Mahmoud AM; Mohammed HM; Khadrawy SM; Galaly SR
    Chem Biol Interact; 2017 Nov; 277():146-158. PubMed ID: 28935427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficient liver regeneration after carbon tetrachloride injury in mice lacking type 1 but not type 2 tumor necrosis factor receptor.
    Yamada Y; Fausto N
    Am J Pathol; 1998 Jun; 152(6):1577-89. PubMed ID: 9626061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
    Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
    Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GPR110 (ADGRF1) mediates anti-inflammatory effects of N-docosahexaenoylethanolamine.
    Park T; Chen H; Kim HY
    J Neuroinflammation; 2019 Nov; 16(1):225. PubMed ID: 31730008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentially expressed MicroRNAs provide mechanistic insight into fibrosis-associated liver carcinogenesis in mice.
    Marrone AK; Shpyleva S; Chappell G; Tryndyak V; Uehara T; Tsuchiya M; Beland FA; Rusyn I; Pogribny IP
    Mol Carcinog; 2016 May; 55(5):808-17. PubMed ID: 25865624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular ATP and Purinergic P2Y
    Schulien I; Hockenjos B; van Marck V; Ayata CK; Follo M; Thimme R; Hasselblatt P
    Cancer Res; 2020 Feb; 80(4):699-708. PubMed ID: 31822494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue inhibitor of metalloproteinase 1 (TIMP-1) deficiency exacerbates carbon tetrachloride-induced liver injury and fibrosis in mice: involvement of hepatocyte STAT3 in TIMP-1 production.
    Wang H; Lafdil F; Wang L; Yin S; Feng D; Gao B
    Cell Biosci; 2011 Apr; 1(1):14. PubMed ID: 21711826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of hepatic stellate cell retinoid lipid droplets does not enhance hepatic fibrosis but decreases hepatic carcinogenesis.
    Kluwe J; Wongsiriroj N; Troeger JS; Gwak GY; Dapito DH; Pradere JP; Jiang H; Siddiqi M; Piantedosi R; O'Byrne SM; Blaner WS; Schwabe RF
    Gut; 2011 Sep; 60(9):1260-8. PubMed ID: 21278145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatoprotective Effects of Grape Seed Procyanidin B2 in Rats With Carbon Tetrachloride-induced Hepatic Fibrosis.
    Wang Z; Zhang Z; Du N; Wang K; Li L
    Altern Ther Health Med; 2015; 21 Suppl 2():12-21. PubMed ID: 26308756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel STAT3 inhibitor, STX-0119, attenuates liver fibrosis by inactivating hepatic stellate cells in mice.
    Choi S; Jung HJ; Kim MW; Kang JH; Shin D; Jang YS; Yoon YS; Oh SH
    Biochem Biophys Res Commun; 2019 May; 513(1):49-55. PubMed ID: 30935693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary iron overload inhibits carbon tetrachloride-induced promotion in chemical hepatocarcinogenesis: effects on cell proliferation, apoptosis, and antioxidation.
    Wang GS; Eriksson LC; Xia L; Olsson J; Stål P
    J Hepatol; 1999 Apr; 30(4):689-98. PubMed ID: 10207812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cav-1 deficiency promotes liver fibrosis in carbon tetrachloride (CCl
    Ji DG; Zhang Y; Yao SM; Zhai XJ; Zhang LR; Zhang YZ; Li H
    Biomed Pharmacother; 2018 Jun; 102():26-33. PubMed ID: 29549726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic inflammation-fibrosis-cancer axis in the rat hepatocellular carcinoma induced by diethylnitrosamine.
    Ding YF; Wu ZH; Wei YJ; Shu L; Peng YR
    J Cancer Res Clin Oncol; 2017 May; 143(5):821-834. PubMed ID: 28238064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ECM1 Prevents Activation of Transforming Growth Factor β, Hepatic Stellate Cells, and Fibrogenesis in Mice.
    Fan W; Liu T; Chen W; Hammad S; Longerich T; Hausser I; Fu Y; Li N; He Y; Liu C; Zhang Y; Lian Q; Zhao X; Yan C; Li L; Yi C; Ling Z; Ma L; Zhao X; Xu H; Wang P; Cong M; You H; Liu Z; Wang Y; Chen J; Li D; Hui L; Dooley S; Hou J; Jia J; Sun B
    Gastroenterology; 2019 Nov; 157(5):1352-1367.e13. PubMed ID: 31362006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.